Pfizer’s implied fair value per share has edged up from US$29.08 to US$29.19, while some price targets on the stock cluster ...

So Pfizer can use debt or cash on its balance sheet to support the dividend until its earnings improve. Notably, the cash ...

As with other pharma companies, much rides on Pfizer's pipeline; it has many promising formulations in late-stage trials.

These healthcare giants have been top dividend stocks for years, and both could be intriguing options to consider right now.

Pfizer (NYSE:PFE) has entered a new alliance with Sarah Cannon Research Institute to accelerate oncology clinical trials and ...

Merck is racing to defend its leadership in the market for cancer drugs ahead of Keytruda’s looming patent cliff. A clinical ...

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Pfizer and its partners have granted Rigel Pharmaceuticals an exclusive license to commercialize VEPPANU (vepdegestrant), the ...

Why Johnson & Johnson’s stability, dividend growth, and buybacks may beat Pfizer’s low valuation and high yield. Read the ...

With short-term rates still elevated, tariff uncertainty churning through earnings models, and credit spreads widening at the ...

Learn more about Pfizer Inc.'s (PFE) stock grades for Value, Momentum, Growth and Estimate Revisions and determine whether ...